AGILENT TECHNOLOGIES INC (A) Stock Fundamental Analysis
USA - NYSE:A - US00846U1016 - Common Stock
146.74 USD
-0.75 (-0.51%)
146.74 USD
0 (0%)
Overall A gets a fundamental rating of 6 out of 10. We evaluated A against 58 industry peers in the Life Sciences Tools & Services industry. While A has a great profitability rating, there are some minor concerns on its financial health. A has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
A had positive earnings in the past year.
A had a positive operating cash flow in the past year.
A had positive earnings in each of the past 5 years.
A had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 9.98%, A belongs to the top of the industry, outperforming 89.66% of the companies in the same industry.
A's Return On Equity of 19.15% is amongst the best of the industry. A outperforms 89.66% of its industry peers.
The Return On Invested Capital of A (12.99%) is better than 87.93% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for A is in line with the industry average of 13.50%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.98% | ||
| ROE | 19.15% | ||
| ROIC | 12.99% |
ROA(3y)11.44%
ROA(5y)10.62%
ROE(3y)22.24%
ROE(5y)20.78%
ROIC(3y)14.65%
ROIC(5y)13.29%
1.3 Margins
With an excellent Profit Margin value of 17.97%, A belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
A's Profit Margin has been stable in the last couple of years.
With an excellent Operating Margin value of 22.44%, A belongs to the best of the industry, outperforming 93.10% of the companies in the same industry.
In the last couple of years the Operating Margin of A has grown nicely.
With a decent Gross Margin value of 52.92%, A is doing good in the industry, outperforming 62.07% of the companies in the same industry.
A's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.44% | ||
| PM (TTM) | 17.97% | ||
| GM | 52.92% |
OM growth 3Y4.07%
OM growth 5Y5.41%
PM growth 3Y1.12%
PM growth 5Y-0.93%
GM growth 3Y0.36%
GM growth 5Y0.01%
2. Health
2.1 Basic Checks
A has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, A has less shares outstanding
A has less shares outstanding than it did 5 years ago.
The debt/assets ratio for A is higher compared to a year ago.
2.2 Solvency
A has an Altman-Z score of 5.59. This indicates that A is financially healthy and has little risk of bankruptcy at the moment.
A has a Altman-Z score of 5.59. This is amongst the best in the industry. A outperforms 84.48% of its industry peers.
The Debt to FCF ratio of A is 3.13, which is a good value as it means it would take A, 3.13 years of fcf income to pay off all of its debts.
A has a better Debt to FCF ratio (3.13) than 79.31% of its industry peers.
A has a Debt/Equity ratio of 0.54. This is a neutral value indicating A is somewhat dependend on debt financing.
A's Debt to Equity ratio of 0.54 is on the low side compared to the rest of the industry. A is outperformed by 63.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.54 | ||
| Debt/FCF | 3.13 | ||
| Altman-Z | 5.59 |
ROIC/WACC1.26
WACC10.33%
2.3 Liquidity
A has a Current Ratio of 2.25. This indicates that A is financially healthy and has no problem in meeting its short term obligations.
A has a Current ratio (2.25) which is in line with its industry peers.
A has a Quick Ratio of 1.71. This is a normal value and indicates that A is financially healthy and should not expect problems in meeting its short term obligations.
A has a Quick ratio of 1.71. This is comparable to the rest of the industry: A outperforms 46.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.25 | ||
| Quick Ratio | 1.71 |
3. Growth
3.1 Past
A shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.61%.
The Earnings Per Share has been growing by 11.14% on average over the past years. This is quite good.
A shows a small growth in Revenue. In the last year, the Revenue has grown by 4.48%.
The Revenue has been growing slightly by 4.75% on average over the past years.
EPS 1Y (TTM)4.61%
EPS 3Y6.82%
EPS 5Y11.14%
EPS Q2Q%3.79%
Revenue 1Y (TTM)4.48%
Revenue growth 3Y1%
Revenue growth 5Y4.75%
Sales Q2Q%10.14%
3.2 Future
Based on estimates for the next years, A will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.99% on average per year.
A is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.88% yearly.
EPS Next Y7.47%
EPS Next 2Y7.72%
EPS Next 3Y8.59%
EPS Next 5Y8.99%
Revenue Next Year6.72%
Revenue Next 2Y6.11%
Revenue Next 3Y6%
Revenue Next 5Y5.88%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 26.92, which means the current valuation is very expensive for A.
Based on the Price/Earnings ratio, A is valued a bit cheaper than the industry average as 77.59% of the companies are valued more expensively.
A is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.06, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 23.90, which indicates a rather expensive current valuation of A.
Compared to the rest of the industry, the Price/Forward Earnings ratio of A indicates a rather cheap valuation: A is cheaper than 81.03% of the companies listed in the same industry.
A is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 32.73, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.92 | ||
| Fwd PE | 23.9 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, A is valued a bit cheaper than 72.41% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of A indicates a somewhat cheap valuation: A is cheaper than 63.79% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 38.24 | ||
| EV/EBITDA | 24 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates A does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of A may justify a higher PE ratio.
PEG (NY)3.61
PEG (5Y)2.42
EPS Next 2Y7.72%
EPS Next 3Y8.59%
5. Dividend
5.1 Amount
A has a yearly dividend return of 0.67%, which is pretty low.
Compared to an average industry Dividend Yield of 0.50, A pays a better dividend. On top of this A pays more dividend than 98.28% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, A's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.67% |
5.2 History
The dividend of A is nicely growing with an annual growth rate of 7.63%!
A has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of A decreased recently.
Dividend Growth(5Y)7.63%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
22.95% of the earnings are spent on dividend by A. This is a low number and sustainable payout ratio.
The dividend of A is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP22.95%
EPS Next 2Y7.72%
EPS Next 3Y8.59%
146.74
-0.75 (-0.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners92.27%
Inst Owner Change-0.9%
Ins Owners0.13%
Ins Owner Change0.04%
Market Cap41.60B
Revenue(TTM)6.79B
Net Income(TTM)1.22B
Analysts76.3
Price Target152.19 (3.71%)
Short Float %1.2%
Short Ratio1.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.67% |
Yearly Dividend0.95
Dividend Growth(5Y)7.63%
DP22.95%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.04%
Min EPS beat(2)-1.64%
Max EPS beat(2)1.56%
EPS beat(4)3
Avg EPS beat(4)0.66%
Min EPS beat(4)-1.64%
Max EPS beat(4)1.57%
EPS beat(8)7
Avg EPS beat(8)1.26%
EPS beat(12)10
Avg EPS beat(12)1.89%
EPS beat(16)13
Avg EPS beat(16)2.06%
Revenue beat(2)2
Avg Revenue beat(2)1.42%
Min Revenue beat(2)0.54%
Max Revenue beat(2)2.3%
Revenue beat(4)2
Avg Revenue beat(4)0.33%
Min Revenue beat(4)-1.23%
Max Revenue beat(4)2.3%
Revenue beat(8)3
Avg Revenue beat(8)-0.06%
Revenue beat(12)6
Avg Revenue beat(12)0.29%
Revenue beat(16)7
Avg Revenue beat(16)0.09%
PT rev (1m)8.21%
PT rev (3m)11.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.87%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)-0.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.92 | ||
| Fwd PE | 23.9 | ||
| P/S | 6.13 | ||
| P/FCF | 38.24 | ||
| P/OCF | 27.83 | ||
| P/B | 6.53 | ||
| P/tB | 29.17 | ||
| EV/EBITDA | 24 |
EPS(TTM)5.45
EY3.71%
EPS(NY)6.14
Fwd EY4.18%
FCF(TTM)3.84
FCFY2.62%
OCF(TTM)5.27
OCFY3.59%
SpS23.94
BVpS22.47
TBVpS5.03
PEG (NY)3.61
PEG (5Y)2.42
Graham Number52.49
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.98% | ||
| ROE | 19.15% | ||
| ROCE | 14.74% | ||
| ROIC | 12.99% | ||
| ROICexc | 15.25% | ||
| ROICexgc | 34.51% | ||
| OM | 22.44% | ||
| PM (TTM) | 17.97% | ||
| GM | 52.92% | ||
| FCFM | 16.03% |
ROA(3y)11.44%
ROA(5y)10.62%
ROE(3y)22.24%
ROE(5y)20.78%
ROIC(3y)14.65%
ROIC(5y)13.29%
ROICexc(3y)17.07%
ROICexc(5y)15.7%
ROICexgc(3y)42.54%
ROICexgc(5y)41.66%
ROCE(3y)16.57%
ROCE(5y)15.04%
ROICexgc growth 3Y-7.71%
ROICexgc growth 5Y-3.01%
ROICexc growth 3Y-0.19%
ROICexc growth 5Y4.58%
OM growth 3Y4.07%
OM growth 5Y5.41%
PM growth 3Y1.12%
PM growth 5Y-0.93%
GM growth 3Y0.36%
GM growth 5Y0.01%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.54 | ||
| Debt/FCF | 3.13 | ||
| Debt/EBITDA | 1.88 | ||
| Cap/Depr | 142.31% | ||
| Cap/Sales | 6% | ||
| Interest Coverage | 17.92 | ||
| Cash Conversion | 82.64% | ||
| Profit Quality | 89.18% | ||
| Current Ratio | 2.25 | ||
| Quick Ratio | 1.71 | ||
| Altman-Z | 5.59 |
F-Score5
WACC10.33%
ROIC/WACC1.26
Cap/Depr(3y)116.28%
Cap/Depr(5y)89.27%
Cap/Sales(3y)4.81%
Cap/Sales(5y)3.93%
Profit Quality(3y)102.27%
Profit Quality(5y)105.09%
High Growth Momentum
Growth
EPS 1Y (TTM)4.61%
EPS 3Y6.82%
EPS 5Y11.14%
EPS Q2Q%3.79%
EPS Next Y7.47%
EPS Next 2Y7.72%
EPS Next 3Y8.59%
EPS Next 5Y8.99%
Revenue 1Y (TTM)4.48%
Revenue growth 3Y1%
Revenue growth 5Y4.75%
Sales Q2Q%10.14%
Revenue Next Year6.72%
Revenue Next 2Y6.11%
Revenue Next 3Y6%
Revenue Next 5Y5.88%
EBIT growth 1Y-5.11%
EBIT growth 3Y5.1%
EBIT growth 5Y10.42%
EBIT Next Year19.73%
EBIT Next 3Y11.85%
EBIT Next 5Y9.19%
FCF growth 1Y-23.38%
FCF growth 3Y1.94%
FCF growth 5Y9.68%
OCF growth 1Y-12.27%
OCF growth 3Y5.65%
OCF growth 5Y11.39%
AGILENT TECHNOLOGIES INC / A FAQ
Can you provide the ChartMill fundamental rating for AGILENT TECHNOLOGIES INC?
ChartMill assigns a fundamental rating of 6 / 10 to A.
What is the valuation status of AGILENT TECHNOLOGIES INC (A) stock?
ChartMill assigns a valuation rating of 4 / 10 to AGILENT TECHNOLOGIES INC (A). This can be considered as Fairly Valued.
Can you provide the profitability details for AGILENT TECHNOLOGIES INC?
AGILENT TECHNOLOGIES INC (A) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for A stock?
The Price/Earnings (PE) ratio for AGILENT TECHNOLOGIES INC (A) is 26.92 and the Price/Book (PB) ratio is 6.53.
What is the financial health of AGILENT TECHNOLOGIES INC (A) stock?
The financial health rating of AGILENT TECHNOLOGIES INC (A) is 6 / 10.